RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

The article has little to do with my hunch. We're in a dog-that-didn't-bark situation: corx's survival appeared to hinge on them for once meeting their deadlines for the IND and for SA completion. Instead, they've blown past their projected completion dates; even for a company that has had a really lousy track record for meeting its self-imposed deadlines, this has been shocking, particularly because the time they gave themselves was more than sufficient for the tasks at hand. We went through something similar with the Biovail announcement. In the recent past, when corx has completely failed to account for why it had missed some rather specific near-term, self-imposed deadlines, a deal near completion was the cause. That's what I think is happening here.

Unfortunately, there is no guarantee the deal will happen. If it doesn't, we're screwed.

Meanwhile, it appears that the pattern of propping up share-price by day's end buys continues.